List of Excipients in Branded Drug 365 WHOLE FOODS MARKET FLUTICASONE PROPIONATE

Generic Drugs Containing 365 WHOLE FOODS MARKET FLUTICASONE PROPIONATE

Company	Ingredient	NDC	Excipient
Whole Foods Market, Inc.	fluticasone propionate	42681-0058	ANHYDROUS DEXTROSE
Whole Foods Market, Inc.	fluticasone propionate	42681-0058	BENZALKONIUM CHLORIDE
Whole Foods Market, Inc.	fluticasone propionate	42681-0058	CARBOXYMETHYLCELLULOSE SODIUM
Whole Foods Market, Inc.	fluticasone propionate	42681-0058	CELLULOSE, MICROCRYSTALLINE

What are the Most Frequently-Used Excipients in 365 WHOLE FOODS MARKET FLUTICASONE PROPIONATE?

# Of NDCs	Excipient
1	ANHYDROUS DEXTROSE
1	BENZALKONIUM CHLORIDE
1	CARBOXYMETHYLCELLULOSE SODIUM
1	CELLULOSE, MICROCRYSTALLINE

Excipient Strategy and Commercial Opportunities for Fluticasone Propionate in Whole Foods Market

Last updated: March 18, 2026

What are the key excipient considerations for Fluticasone Propionate marketed via Whole Foods?

Fluticasone Propionate is a corticosteroid used primarily in inhalers for asthma and allergic rhinitis. Delivering it as an OTC or natural product through Whole Foods Market involves specialized excipient selection to meet regulatory, marketing, and safety standards.

Primary Excipients in Commercial Fluticasone Propionate Inhalers

Commercial formulations typically use:

• Propellants (HFA 134a or HFA 134a/HFA 152a mixture)
• Absorptive excipients (lactose, for dry powder inhalers)
• Surfactants (polysorbates or phospholipids)
• Stabilizers (ascorbic acid or citric acid)
• Diluents and carriers

In the Whole Foods context, excipient choices must align with "natural" or "clean label" principles. Common restrictions involve avoiding artificial solvents, preservatives, or allergens.

Excipient Strategy for Whole Foods Market

1. Natural Carriers: Use of lactose monohydrate or alternative natural carriers such as plant-derived powders.
2. Minimal Synthetic Additives: Replace synthetic surfactants with plant-based surfactants or emulsifiers (e.g., lecithin, saponins).
3. Eco-Friendly Propellants: Shift from traditional HFA propellants to environmentally friendly, possibly hydrocarbon-based propellants compliant with green standards.
4. Allergen Considerations: Verify absence of gluten, soy, or dairy derivatives to match Whole Foods' allergen standards.

Regulatory Considerations

• Must comply with FDA regulations under monographs or new drug applications (NDAs).
• For OTC status, adhere to FDA's monograph for nasal and inhalation corticosteroids.
• Whole Foods' non-GMO, organic, or allergen-free claims can impose additional constraints on excipient selection.

What are the commercial opportunities for Fluticasone Propionate within Whole Foods Market?

Market Potential Assessment

• Whole Foods Market targets health-conscious consumers preferring natural, minimally processed formulations.
• The global allergy and asthma markets are projected to reach USD 50.4 billion by 2027, with increasing demand for OTC options in natural formats.
• An alternative formulation aligning with "clean label" criteria could command premium pricing.

Positioning and Branding

• Market as a "Natural Respiratory Support" product, emphasizing plant-based excipients.
• Leverage certifications like USDA Organic, Non-GMO Project Verified, and allergen-free.
• Collaborate with third-party testing labs to validate excipient purity and safety.

Distribution Channels and Pricing

• Sold through Whole Foods' physical stores and online platform.
• Price premiums ranging from 30% to 50% over conventional inhalers could be feasible, given consumer preferences for natural products.
• Smaller, localized batches might enable premium positioning and facilitate regulatory navigation.

Challenges

• Regulatory approval for OTC inhalers with natural excipients.
• Ensuring bioequivalence and therapeutic efficacy.
• Developing stable formulations with plant-based excipients.

Opportunities

• Expand product line to include nasal sprays, dry powders, or alternative delivery systems.
• Develop a complementary line of natural supplements for respiratory health.
• Target wellness segments within Whole Foods, capitalizing on the organic and clean label trends.

What are the key issues in developing excipient strategies for natural formulations?

Issue	Consideration
Excipient purity	Must meet pharmaceutical-grade standards
Stability	Plant-based excipients may pose stability challenges
Regulatory compliance	Must align with FDA, USDA, and local agency standards
Consumer expectations	Clear labeling regarding "natural," "organic," allergen-free

What are the key takeaways?

• Customized excipient strategies for Whole Foods require replacing synthetic additives with natural, allergen-free, and eco-friendly alternatives.
• Packaging and branding should emphasize natural, organic credentials to align with Whole Foods' consumer base.
• Market entry involves navigating both regulatory approval pathways and consumer perception.
• Potential exists to command premium pricing through differentiation based on natural formulations.
• Stable formulation development and compliance with stringent standards remain critical challenges.

FAQs

1. How can excipient selection impact regulatory approval for natural inhalers?

   • Excipient choices influence regulatory compliance; natural, non-synthetic excipients must meet quality standards and demonstrate safety.

2. Are plant-based surfactants effective alternatives in inhaler formulations?

   • Yes, plant-based surfactants like lecithin or saponins can serve as effective emulsifiers, but require stability testing.

3. What certification claims support natural respiratory products?

   • USDA Organic, Non-GMO Project Verified, allergen-free, and eco-friendly certifications help build consumer trust.

4. Can natural excipients affect the bioavailability of Fluticasone Propionate?

   • Yes, excipients can influence drug delivery efficacy; formulation optimization is necessary to ensure consistent dosing.

5. What are the consumer preferences influencing product success at Whole Foods?

   • Preferences include organic, non-GMO, allergen-free, environmentally friendly, and clean label products.

---

References

1. U.S. Food and Drug Administration. (2021). Regulations for inhalation and nasal products. https://www.fda.gov
2. MarketsandMarkets. (2022). Allergy treatment market by type, route of administration, and region. https://www.marketsandmarkets.com
3. Organic Trade Association. (2023). Guidelines for natural and organic product labeling. https://ota.com
4. European Medicines Agency. (2020). Guidelines on harmonization of requirements for inhalation and nasal products. https://www.ema.europa.eu
5. WHO. (2023). Global asthma report 2023. https://www.who.int